dabigatran has been researched along with Dysarthosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaneko, N; Ohtani, T; Sintoku, R; Yajima, T | 1 |
1 other study(ies) available for dabigatran and Dysarthosis
| Article | Year |
|---|---|
Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report.
Topics: Aged; Antibodies, Monoclonal, Humanized; Dabigatran; Dysarthria; Female; Humans; Paresis; Stroke; Tissue Plasminogen Activator; Treatment Outcome | 2019 |